Avandia (Rosiglitazone maleate; also marketed as Avandia, Avandamet, Avandaryl)
A risk with the use of Rosiglitazone, a primary component in Avandia, as related to increased risk of heart problems in the users of the drug has been acknowledged since 2001. However, new data concerning Rosiglitazone suggests that new cardiac-related risks, although small, are apparent. This preliminary information has caused the FDA to give attention to the potential dangers of the drug although no final determinations have been made. An increased sense of awareness of potential dangers is being called for and cautionary measures are urged regarding the use of the drug in patients who have a history of heart related difficulties. Steady monitoring is also advised regarding heart, liver and eye health of patients taking the drug.
With over 85 combined years of experience, defective drug lawyers Ryan Krebs, Timothy Cappolino, Richard Dodd, Craig Brown, Valerie Farwell and Ursula Keen have successfully helped patients with physical difficulties and their families find justice and treatment options. Ryan Krebs, MD, JD a defective drug lawyer, has devoted his life to the studies of medicine and law. Working with an attorney who is also a doctor further ensures that your case will be handled by not only one of the most qualified and renowned attorneys in the country but by a doctor who understands the medical aspects of your case as well. The staff of Cappolino Dodd Krebs LLP recognizes the difficult time you are facing. As always, we welcome the opportunity to discuss your situation as well as your future options at no charge. We want to help victims of defective drugs and medical malpractice issues seek legal advice and treatment options. If you or a loved one was injured after using a Avandia, you may have grounds for an Avandia lawsuit. Please contact our Avandia attorneys today for help!
|
| |
|
|
